Paper15917238
CD47 augments Fas/CD95-mediated apoptosis.
Manna PP and 3 others. J Biol Chem, 2005. Cited by 65 papers, by iCite.
Cite this record
ConductScience Library. CD47 augments Fas/CD95-mediated apoptosis. Papers, record 15917238. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15917238
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, CD | Major topic |
| Apoptosis | Major topic |
| fas Receptor | Major topic |
| Animals | |
| CD47 Antigen | |
| Humans | |
| Jurkat Cells | |
| Mice | |
| Mice, Inbred C57BL |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| GM57573 | NIGMS NIH HHS | United States | R01GM057573 | PubMed and NIH | NIH RePORTER |
| HL54390 | NHLBI NIH HHS | United States | R01HL054390 | PubMed and NIH | NIH RePORTER |
| R29GM057573 | NIH | NIH RePORTER | |||
| R55HL054390 | NIH | NIH RePORTER | |||
| R56HL054390 | NIH | NIH RePORTER |
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41511354 | If Plan A Does Not Work: The CD47 Ectodomain as a Target for Immune Tolerance. | Cells | 2025 | https://conductscience.org/library/papers/41511354 | PubMed |
| 41152907 | New power in cancer immunotherapy: the rise of chimeric antigen receptor macrophage (CAR-M). | J Transl Med | 2025 | https://conductscience.org/library/papers/41152907 | PubMed |
| 40630093 | CD47-mediated regulation of glucose and lipid metabolism: implications for the pathogenesis of MASLD. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40630093 | PubMed |
| 40334763 | Refolding of the recombinant IgV domain of CD47 from E. coli for NMR studies. | Protein Expr Purif | 2025 | https://conductscience.org/library/papers/40334763 | PubMed |
| 40133488 | Regulating islet stress responses through CD47 activation. | Diabetologia | 2025 | https://conductscience.org/library/papers/40133488 | PubMed |
| 40100495 | Targeting "don't eat me" signal: breast cancer immunotherapy. | Breast Cancer Res Treat | 2025 | https://conductscience.org/library/papers/40100495 | PubMed |
| 40082799 | Evaluation of thrombospondin 1 as a novel biomarker in pediatric-onset systemic lupus erythematosus. | BMC Pediatr | 2025 | https://conductscience.org/library/papers/40082799 | PubMed |
| 39167629 | Deciphering the role of CD47 in cancer immunotherapy. | J Adv Res | 2024 | https://conductscience.org/library/papers/39167629 | PubMed |
| 38362603 | Tolerating CD47. | Clin Transl Med | 2024 | https://conductscience.org/library/papers/38362603 | PubMed |
| 38125492 | The role of CD47 in non-neoplastic diseases. | Heliyon | 2023 | https://conductscience.org/library/papers/38125492 | PubMed |
| 36293358 | Targeting CXCR4 and CD47 Receptors: An Overview of New and Old Molecules for a Biological Personalized Anticancer Therapy. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36293358 | PubMed |
| 36105746 | Loss of CD47 alters CD8+ T cell activation in vitro and immunodynamics in mice. | Oncoimmunology | 2022 | https://conductscience.org/library/papers/36105746 | PubMed |
| 35978372 | Targeting macrophages in hematological malignancies: recent advances and future directions. | J Hematol Oncol | 2022 | https://conductscience.org/library/papers/35978372 | PubMed |
| 35795660 | CD47-SIRPα Controls ADCC Killing of Primary T Cells by PMN Through a Combination of Trogocytosis and NADPH Oxidase Activation. | Front Immunol | 2022 | https://conductscience.org/library/papers/35795660 | PubMed |
| 35565443 | CXCR4/CXCL12 Activities in the Tumor Microenvironment and Implications for Tumor Immunotherapy. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35565443 | PubMed |
| 34707698 | CD47 (Cluster of Differentiation 47). | Atlas Genet Cytogenet Oncol Haematol | 2021 | https://conductscience.org/library/papers/34707698 | PubMed |
| 34106789 | CD47 and thrombospondin-1 regulation of mitochondria, metabolism, and diabetes. | Am J Physiol Cell Physiol | 2021 | https://conductscience.org/library/papers/34106789 | PubMed |
| 33925464 | Functions of Thrombospondin-1 in the Tumor Microenvironment. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33925464 | PubMed |
| 33920030 | Thrombospondin-1 CD47 Signalling: From Mechanisms to Medicine. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33920030 | PubMed |
| 33224442 | CD47 (Cluster of differentiation 47): an anti-phagocytic receptor with a multitude of signaling functions. | Anim Cells Syst (Seoul) | 2020 | https://conductscience.org/library/papers/33224442 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD47 | 961 | Swiss-Prot's references | https://conductscience.org/library/genes/961 | NCBI Gene |
| CYCS | 54205 | PubTator's text mining | https://conductscience.org/library/genes/54205 | NCBI Gene |
| FAS | 355 | PubTator's text mining | https://conductscience.org/library/genes/355 | NCBI Gene |
| FASLG | 356 | PubTator's text mining | https://conductscience.org/library/genes/356 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/15917238
GET https://conductscience.org/api/papers/v1/15917238/cited_by?page=2